Trials / Completed
CompletedNCT04367545
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to develop and validate a molecular diagnostic strategy (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR method, in order to : 1. to compensate for the risk of a shortage of diagnostic kits, reagents and materials necessary for molecular diagnosis; 2. to increase the molecular diagnostic capacity of COVID-19 at the Rouen University Hospital; 3. and to have a method compatible with screening extended to populations at risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Saliva collection | Saliva collection will be done in addition to standard diagnosis collection (nasopharyngeal collection using swab) |
Timeline
- Start date
- 2020-04-16
- Primary completion
- 2020-05-17
- Completion
- 2020-05-17
- First posted
- 2020-04-29
- Last updated
- 2026-04-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04367545. Inclusion in this directory is not an endorsement.